Co-authored by investigators of VHIO’s Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results…
VIGex
Gilead Sciences, in collaboration with the Carlos III Health Institute (ISCIII), held the award ceremony for the 10th Edition of…
Developed by VHIO investigators, VIGex is a gene expression signature that classifies solid tumors into three categories based on the…
